Investigation of the ALLEGRA THV System With a New Delivery System in Patients With Aortic Stenosis or Failed Surgical Bioprosthesis
Condition: Transcatheter Aortic Valve Implantation Intervention: Device: (ALLEGRA Transcatheter Heart Valve) TAVI in severe calcified aortic stenosis or in failed surgical aortic bioprosthesis Sponsor: NVT GmbH Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Allegra | Aortic Stenosis | Cardiology | Heart | Heart Valve Disease | Heart Valves | Research